MTRAC issued a new Commissioning Support review in January 2014. The review covers dapoxetine.
The dapoxetine (Priligy®) summary advises that this drug is suitable for restricted prescribing in primary care for the treatment premature ejaculation. The review notes that the evidence for this treatment is relatively strong but notes that accurate diagnosis of this condition requires referral to a specialist psychosexual health clinic.
Action: Clinicians should be aware of these reviews and use the recommendations to guide appropriate use of these medicines in current practice.
|« SMC Update - January 2014||NICE Guidance - January 2014 »|